Healthy Minds Program (HMP) App for Hip structure

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Wisconsin, Madison, WI
Hip structure
Healthy Minds Program (HMP) App - Behavioral
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

Hip preservation surgery patients experience physical trauma, both in the physical injury itself and following surgery, and face potential long-lasting effects such as muscle weakness or diminished joint function, hip pain, and fear. Many of these patients report greater anxiety and depression following surgery, which can further compound negative outcomes in these patients. This study is a single-blind, randomized controlled trial design to evaluate the effects of a remotely-delivered 8-week mindfulness intervention on patient-reported outcomes following hip preservation surgery.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

6 Primary · 1 Secondary · Reporting Duration: baseline, 3 months, 6 months, 12 months, 24 months

Month 24
Change in Hip Outcome Score (HOS-ADL and HOS-SS)
Change in International Hip Outcome Tool (IHOT) Score
Change in Modified Harris Hip Score (mHHS)
Change in PROMIS Anxiety and Depression Questionnaire Score
Change in PROMIS Global Health Questionnaire (GHQ) Score
Change in Single Assessment Numeric Evaluation (SANE) Score
Summary of Pain Locations
up to 24 months
Total Duration of Mindfulness Training in the Mindfulness Group

Trial Safety

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
Mindfulness Intervention plus Standard of Care
1 of 2
Active Control
Experimental Treatment

200 Total Participants · 2 Treatment Groups

Primary Treatment: Healthy Minds Program (HMP) App · No Placebo Group · N/A

Mindfulness Intervention plus Standard of Care
Behavioral
Experimental Group · 1 Intervention: Healthy Minds Program (HMP) App · Intervention Types: Behavioral
Standard of CareNoIntervention Group · 1 Intervention: Standard of Care · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 3 months, 6 months, 12 months, 24 months
Closest Location: University of Wisconsin · Madison, WI
Photo of wi university of wisconsin 1Photo of madison 2Photo of madison 3
2003First Recorded Clinical Trial
0 TrialsResearching Hip structure
381 CompletedClinical Trials

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,052 Previous Clinical Trials
2,559,711 Total Patients Enrolled
Andrew Watson, MD, MSPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
200 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are 18-45 years old.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.